{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T21:25:01Z","timestamp":1772313901237,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.juro.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T14:43:03Z","timestamp":1486996983000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.1097","volume":"198","author":[{"given":"Yao-Chi","family":"Chuang","sequence":"first","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gang Memorial Hospital, College of Medicine, Chang Gung University, Hualien, Taiwan"},{"name":"Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien (HCK), Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gang Memorial Hospital, College of Medicine, Chang Gung University, Hualien, Taiwan"},{"name":"Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien (HCK), Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.02.021_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/nau.20687","article-title":"Status of international consensus on interstitial cystitis\/bladder pain syndrome\/painful bladder syndrome: 2008 snapshot","volume":"28","author":"Hanno","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.02.021_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","article-title":"Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States","volume":"186","author":"Berry","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/13543784.2016.1162290","article-title":"Investigational drugs for bladder pain syndrome (BPS)\/interstitial cystitis (IC)","volume":"25","author":"Chuang","year":"2016","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.juro.2017.02.021_bib4","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02000309","article-title":"Interstitial cystitis: an unsolved enigma","volume":"4","author":"Moutzouris","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.juro.2017.02.021_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.juro.2017.02.021_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1464-410X.2010.09317.x","article-title":"Botulinum toxin for the lower urinary tract","volume":"105","author":"Chuang","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.02.021_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/nau.22508","article-title":"Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium","volume":"34","author":"Hanna-Mitchell","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.02.021_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.02.021_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin a delivery using liposomes","volume":"182","author":"Chuang","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxinA for patients with overactive bladder: a single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxinA improves overactive bladder symptoms: a prospective, multi-center, double blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib13","series-title":"Campbell\u2019s Urology, 7th ed","first-page":"631","article-title":"Interstitial cystitis and related diseases","author":"Hanno","year":"1998"},{"key":"10.1016\/j.juro.2017.02.021_bib14","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Interstitial Cystitis. National Institutes of Health, Bethesda, Maryland, August 28-29, 1987."},{"key":"10.1016\/j.juro.2017.02.021_bib15","first-page":"109","article-title":"Intravesical botulinum toxin\u00a0A injections do not benefit patients with ulcer type interstitial cystitis","volume":"16","author":"Lee","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.juro.2017.02.021_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0090-4295(01)01126-8","article-title":"Psychometric validation of the O'Leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium","volume":"57","author":"Lubeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.02.021_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/nau.20082","article-title":"Overactive bladder and painful bladder syndrome: there need not be confusion","volume":"24","author":"Abrams","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.02.021_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","article-title":"Safety and efficacy of intravesical liposome versus oral pentosan polysulfate in patients with interstitial cystitis\/painful bladder syndrome","volume":"182","author":"Chuang","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.juro.2016.06.089","article-title":"Sensory hyperinnervation distinguishes bladder pain syndrome\/interstitial cystitis from overactive bladder syndrome","volume":"197","author":"Regauer","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urology.2014.04.011","article-title":"Examination of the significant placebo effect in the treatment of interstitial cystitis\/bladder pain syndrome","volume":"84","author":"Bosch","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.02.021_bib21","doi-asserted-by":"crossref","first-page":"865463","DOI":"10.1155\/2014\/865463","article-title":"Evidence for\u00a0bladder urothelial pathophysiology in functional bladder disorders","volume":"2014","author":"Keay","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.juro.2017.02.021_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan polysulfate sodium for treatment of\u00a0interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.juro.2009.02.122","article-title":"Clinical phenotyping of women with interstitial cystitis\/painful bladder syndrome: a key to classification and potentially improved management","volume":"182","author":"Nickel","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.02.021_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/nau.22760","article-title":"Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Kuo","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.02.021_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-016-0767-3","article-title":"Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial","volume":"15","author":"Rief","year":"2017","journal-title":"BMC Med"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717302288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717302288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.02.021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:38:32Z","timestamp":1651207112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.02.021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1016\/j.juro.2017.02.021"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.02.021","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis\/Bladder Pain Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}